Abstract
| Anesthesia and Pain Medicine. 2006 Mar. 10(1): 31-34 ⓒ Korean Society for Intravenous Anesthesia |
|
|
| |
| Total Intravenous Anesthesia with Propofol and Remifentanil in End-stage Renal Disease for Coronary Artery Bypass Grafting Surgery -A case report- |
| Hae Kwang Lee, M.D., Byung Hoon Yoo, M.D., Seoung Hoon Woo, M.D., and Jae Kwang Yum, M.D.* |
| Departments of Anesthesiology and Pain Clinic, *Orthopedic Surgery, Sanggye Paik Hospital,College of Medicine, Inje University, Seoul, Korea |
|
| |
| Chronic kidney disease or end-stage renal disease has high prevalence in morbidity and mortality. Cardiovascular disease accounts for over 50% of death in patients with end-stage renal disease. A 58-year-old patient who was receiving hemodialysis because of end-stage renal disease developed unstable angina pectoris with three vessel disease. We performed successful anesthesia for coronary artery bypass grafting (CABG) surgery, using remifenanil and propofol and achieved a stabilized hemodynamic change. |
| |
| Key words : coronary artery bypass grafting, end-stage renal disease, remifentanil. |
| 중심단어 : |
|
| |
|
|
